Constrained functional additive models for estimating interactions
  between a treatment and functional covariates by Park, Hyung et al.
Constrained functional additive models
for estimating interactions between a treatment and
functional covariates
HYUNG G. PARKa∗, EVA PETKOVAa, THADDEUS TARPEYa, R. TODD OGDENb
a Division of Biostatistics, Department of Population Health, New York University
b Department of Biostatistics, Columbia University
Abstract
A novel functional additive model is proposed which is uniquely modified and constrained to model nonlinear
interactions between a treatment indicator and a potentially large number of functional/scalar covariates. We
generalize functional additive regression models by incorporating treatment-specific components into additive
effect components. A structural constraint is imposed on the treatment-specific components, to give a class
of orthogonal main and interaction effect additive models. If primary interest is in interactions, we can avoid
estimating main effects, obviating the need to specify their form and thereby avoiding the issue of model
misspecification. The methods are illustrated with data from a clinical trial with imaging data as predictors.
Keywords: Individualized treatment rules, functional additive regression, sparse additive models, treatment
effect-modifiers
1 Introduction
We propose a flexible approach to estimate the interaction effects between a treatment variable and pretreat-
ment covariates on a treatment response, allowing both scalar-valued and functional-valued pretreatment
covariates. Recent advances in biomedical imaging, mass spectrometry, and high-throughput gene expression
technology produce massive amounts of data on individual patients, and open up the possibility of tailoring
treatments to the biosignatures of individual patients from individual-specific data (McKeague and Qian,
2014). Notably, some randomized clinical trials (e.g., Trivedi et al., 2016) are designed to discover biosignatures
that characterize patient heterogeneity in treatment responses from vast amounts of patient pretreatment
profiles. In such studies, the objective is to make individualized treatment decision rules (ITRs) based on
pretreatment patient characteristics such as genetic information (e.g., van’t Veer and Bernards, 2008) and
brain structure and function measured from neuroimaging modalities such as magnetic resonance imaging
(MRI), functional magnetic resonance imaging (fMRI), electroencephalogram (EEG), among others. Our
interest here is in some specific types of high dimensional patient characteristics that are observed in the form
of curves or images. Such data can be viewed as functional (e.g., Ramsay and Silverman, 1997), and such
data are becoming increasingly prevalent in modern randomized clinical trials as pretreatment covariates.
Much work has been carried out to develop methods for optimizing ITRs using data from randomized clinical
trials. Regression-based methodologies are intended to optimize ITRs by estimating treatment-specific mean
response functions (e.g., Gunter et al., 2011; Jeng et al., 2018; Lu et al., 2011; Qian and Murphy, 2011; Shi
et al., 2016; Tian et al., 2014; Zhang et al., 2012) while attempting to maintain robustness with respect to
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model misspecification. Machine learning approaches for developing ITRs are often framed in the context of
classification problems (Zhang et al., 2012; Zhao et al., 2019); for example, outcome weighted learning (e.g.,
Song et al., 2015; Zhao et al., 2012, 2015) based on support vector machines, tree-based classification (e.g.,
Laber and Zhao, 2015), and adaptive boosting (Kang et al., 2014), among others. However, to date there has
been relatively little research on methods for developing ITRs based on pretreatment functional covariates.
McKeague and Qian (2014) propose methods for estimating and evaluating treatment regimes that depend
upon a single pretreatment functional covariate. Ciarleglio et al. (2015, 2018) proposed methods that allow
ITRs to depend on multiple functional/scalar covariates while performing both estimation and covariate
selection for ITRs, when a functional linear model is assumed for the treatment and covariate interactions.
Ciarleglio et al. (2016) consider a flexible functional regression approach to estimating ITRs based upon a
single pretreatment functional covariate.
In this paper, we propose a flexible functional regression method that allows multiple functional/scalar
covariates and performs both estimation and covariate selection for ITRs, without restricting to a linear
underlying model. This approach generalizes the method of Ciarleglio et al. (2018) to allow for nonlinear
underlying relationships between treatment and pretreatment covariates in their effects on the treatment
response and also for more than two treatment conditions. Specifically, we develop a variant of a functional
additive regression model of Fan et al. (2014, 2015), uniquely constrained to model possibly nonlinear
interaction effects between treatment and pretreatment functional/scalar covariates. A sparse nonlinear
combination of 1-dimensional projections of the functional covariates is derived via a sparse additive model
formulation (Fan et al., 2014, 2015; Ravikumar et al., 2009). This approach results in a simple yet flexible
functional regression model useful for estimating treatment-by-covariates interactions and developing ITRs.
2 Constrained functional additive models
We consider a treatment response variable Y ∈ R, a set of p functional-valued covariates X = (X1, . . . , Xp),
and a set of q scalar-valued covariates Z = (Z1, . . . , Zq) ∈ Rq. We will assume that each Xj is a square
integrable random function defined on a compact interval, taken to be [0, 1] without loss of generality. Suppose
the treatment A ∈ {1, . . . , L} (i.e., there are L available treatment conditions) is assigned with associated
known probabilities (pi1, . . . , piL), such that
∑L
a=1 pia = 1 and pia > 0, independent of all pretreatment
covariates. We note that this is readily extended to the case in which treatment assignment is correlated
with the covariates, in which case the probabilities (pi1, . . . , piL) should be replaced by the propensity scores
(pi1(X,Z), . . . , piL(X,Z)), that would typically have to be estimated from observed data.
In this context we focus on the problem of estimating the interactions between the treatment variable A and
a set of functional/scalar covariates (X,Z), on their effects on Y . For a single decision point, an ITR, which
we denote as D, maps an individual with pretreatment characteristics (X,Z) to one of the treatment options
in {1, . . . , L} for a treatment recommendation. One natural measure for the effectiveness of an ITR D is the
so-called “value” (V ) function (Murphy, 2005), V (D) = E[E[Y |X,Z, A = D(X,Z)]], which is the expected
treatment response under the given treatment assignment regime D. If we assume that a larger value of
Y is better (without loss of generality), then the optimal ITR, which we denote as Dopt, can be naturally
defined to be the rule D that maximizes the “value” V (D). It can be easily shown that such an optimal
rule Dopt satisfies: Dopt(X,Z) = arg maxa∈{1,...,L} E[Y |X,Z, A = a]. Qian and Murphy (2011) noted that
Dopt(X,Z) depends only on the (X,Z)-by-A interaction effect, and does not depend on the “main” effect
of (X,Z) on Y . Therefore, in terms of developing ITRs, the (X,Z) main effect on Y , i.e., E[Y |X,Z], is
considered as “nuisance”.
Our approach to developing ITRs is then to express the conditional expectation function E[Y |X,Z, A]
in terms of a main effect for (X,Z) (represented by a function µ) and an A-by-(X,Z) interaction effect
(represented by a function θ), and focus on the estimation of the interaction effect, as in advantage learning
(A-learning; Robins, 2004). Consider the following decomposition of the conditional expectation:
E[Y |X,Z, A] = µ(X,Z)︸ ︷︷ ︸
(X,Z) “main” effect
+ θ(X,Z, A)︸ ︷︷ ︸
A-by-(X,Z) interactions
, (1)
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where the first term µ(X,Z) does not depend on A and only the second term θ(X,Z, A) is a function of A.
Under representation (1), the marginal effect of (X,Z) on Y , i.e., E[Y |X,Z], is expressed as:
E[Y |X,Z] = E[E[Y |X,Z, A]|X,Z]
= E[µ(X,Z) + θ(X,Z, A)|X,Z]
= µ(X,Z) + E[θ(X,Z, A)|X,Z]
(2)
In what follows, for the identifiability of decomposition (1), we will set:
E[θ(X,Z, A)|X,Z] = 0, (3)
which implies, from (2), E[Y |X,Z] = µ(X,Z), i.e., the term µ(X,Z) in (1) represents the (X,Z) marginal
effect, and the second term θ(X,Z, A) in (1) represents the “pure” A-by-(X,Z) interaction effect. We shall
focus only on the “pure” interaction effect term θ(X,Z, A) in (1), since the term µ(X,Z) in (1) can be
viewed a “nuisance” for the purpose of optimizing ITRs. In particular, in this paper, we shall represent
θ(X,Z, A) based on a set of functional additive regression models (FAM) of Fan et al. (2015):
θ(X,Z, A = a) =
p∑
j=1
gj,a(〈βj , Xj〉) +
q∑
k=1
hk,a(Zk) (a = 1, . . . , L), (4)
where the treatment level a-specific component functions {gj,a(·), j = 1, . . . , p} ∪ {hk,a(·), k = 1, . . . , q} are
general square-integrable 1-dimensional (1-D) functions defined on compact intervals on R. Each functional
covariate Xj(·) appears in model (4) as a 1-D projection 〈βj , Xj〉 :=
∫ 1
0 βj(s)Xj(s)ds ∈ R, through an inner
product with a square integrable coefficient function βj(·) defined on [0, 1]. Due to the unspecified nature of
the component function gj,a(·) in (4), for model identifiability, we assume that the coefficient functions βj(·)
have a unit L2 norm; let Θ denote such a space of functions defined over [0, 1], and assume βj ∈ Θ (without
loss of generality).
Under the general framework (1), model (4) for the A-by-(X,Z) interactions gives the following model:
E[Y |X,Z, A = a] = µ(X,Z)︸ ︷︷ ︸
(X,Z) “main” effect
+
p∑
j=1
gj,a(〈βj , Xj〉) +
q∑
k=1
hk,a(Zk)︸ ︷︷ ︸
A-by-(X,Z) interactions
(a = 1, . . . , L)
(5)
where the system of L models (4) θ(X,Z, A = a) (a = 1, . . . , L) determines the A-by-(X,Z) interaction
effect, and the term µ(X,Z) represents an unspecified “main” effect of (X,Z), whose effect does not depend
on the treatment variable A.
As in the general model (1), we impose the identifiability constraint (3) on model (4). Given the additive
model representation of θ(X,Z, A) for each treatment level A = a (a = 1, . . . , L), it is straightforward to
verify that the following condition on the component functions {gj,a}a∈{1,...,L} and {hk,a}a∈{1,...,L} of model
(4):
E[gj,A(〈Xj , βj〉)|Xj ] = 0 (almost surely) (∀βj ∈ Θ) (j = 1, . . . , p) and
E[hk,A(Zk)|Zk] = 0 (almost surely) (k = 1, . . . , q)
(6)
satisfies the identifiability condition (3) of decomposition (1), i.e., imposition of (6) on the proposed model
(5) results in: E[θ(X,Z, A)|X,Z] = E[∑pj=1 gj,A(〈Xj , βj〉) +∑qk=1 hk,A(Zk)|X,Z] = 0 (almost surely) and
satisfies the identifiability condition (3). We call model (5), subject to the constraint (6), a constrained
functional additive model (CFAM) for the A-by-(X,Z) interaction effects. For model (5), we assume an
additive noise structure Y = E[Y |X,Z, A] + , where  ∈ R is a zero-mean random variable with finite
variance, independent of X, Z and A.
Notation. Throughout, we use the notation 〈·, ·〉 to denote the inner product between two square integrable
functions. We consider sets of random variables (A, 〈β,X〉) and measurable functions g(·)(·) on (A, 〈β,X〉),
with the L2 norm of the function g(·)(·) defined as ‖g‖ =
√
E
[
g2A(〈β,X〉)
]
where the expectation is taken with
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respect to the joint distribution of (A, 〈β,X〉) (which depends on β). Similarly, we consider sets of random
variables (A,Z) and measurable functions h(·)(·) on (A,Z), with the L2 norm of the function h(·)(·) defined as
‖h‖ =
√
E
[
h2A(Z)
]
where the expectation is taken with respect to the joint distribution of (A,Z). For a given β,
let us denote the L2 space of functions on the variables (A, 〈β,X〉) as H(β) = {g | E[gA(〈β,X〉)] = 0, ‖g‖ <∞},
with inner product on the space defined as 〈g, f〉 = E[gA(〈β,X〉)fA(〈β,X〉)]. Similarly, let us denote the L2
space of functions on (A,Z) as H = {h | E[hA(Z)] = 0, ‖h‖ <∞}, with inner product on the space similarly
defined. Sometimes, for the notational simplicity, we also write g := gA(〈β,X〉) (and also h := hA(Z)).
For CFAM (5), we can specify the “true” underlying functions of interest, which we denote as g∗j (j = 1, . . . , p),
β∗j (j = 1, . . . , p) and h∗k (k = 1, . . . , q), associated with the A-by-(X,Z) interaction effect terms, as the
solution to the following constrained optimization:
{g∗j , β∗j , h∗k} = argmin
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y − µ(X,Z)−
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2]
subject to E[gj,A(〈Xj , βj〉)|Xj ] = 0 ∀βj ∈ Θ (j = 1, . . . , p) and
E[hk,A(Zk)|Zk] = 0 (k = 1, . . . , q),
(7)
where µ(X,Z) is the true “main” effect function specified in model (5) (and is considered as fixed in (7)).
Since the minimization in (7) is in terms of {gj , βj , hk}, the right-hand side of (7) can be reduced to (by
expanding the first line, i.e., by expanding the expected squared error term in (7)):
arg min
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2
+ 2µ(X,Z)
{ p∑
j=1
gj,A(〈Xj , βj〉) +
q∑
k=1
hk,A(Zk)
}]
= arg min
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2
+ 2µ(X,Z)E
[ p∑
j=1
gj,A(〈Xj , βj〉) +
q∑
k=1
hk,A(Zk)|X,Z
]]
= arg min
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2]
,
in which the first equality follows from an application of the iterated expectation rule to condition on (X,Z),
and the second equality is the result of the constraints imposed in (7): E[gj,A(〈Xj , βj〉)|Xj ] = 0, ∀βj ∈
Θ (j = 1, . . . , p) and E[hk,A(Zk)|Zk] = 0 (k = 1, . . . , q). Therefore, the optimization-based representation (7)
for the “true” underlying functions {g∗j , β∗j , h∗k} of CFAM (5) can be simplified to:
{g∗j , β∗j , h∗k} = argmin
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2]
subject to E[gj,A(〈Xj , βj〉)|Xj ] = 0 ∀βj ∈ Θ (j = 1, . . . , p) and
E[hk,A(Zk)|Zk] = 0 (k = 1, . . . , q),
(8)
which does not involve the term µ(X,Z) of (5). When the “nuisance” functional µ(X,Z) in (5) is a
complicated functional to specify correctly, utilizing the representation (8) for specifying the component
functions {g∗j , j = 1, . . . , p} ∪ {h∗k, k = 1, . . . , q} and the single-index coefficient functions {β∗j , j = 1, . . . , p} of
interest is particularly appealing.
In regression models for a treatment outcome, treatment effect-modifiers are covariates that modify the
effect of the treatment A on the outcome variable Y . Under model (5), the potential treatment effect-
modifiers among the covariates {Xj , j = 1, . . . , p} ∪ {Zk, k = 1, . . . , q}, that associate the treatment variable
A to the treatment outcome Y , enter the model only through the A-by-(X,Z) interaction effect terms∑p
j=1 gj,a(〈Xj , βj〉) +
∑q
k=1 hk,a(Zk) (a = 1, . . . , L). Ravikumar et al. (2009) proposed a sparse additive
model (SAM) for component selection in a high-dimensional additive regression on scalar-valued covariates.
4
As in SAM, to deal with a large p+ q and to achieve treatment effect-modifier selection, we impose sparsity
on the set of the component functions {gj , j = 1, . . . , p; hk, k = 1, . . . , q} in CFAM (5), under the often
reasonable assumption that most covariates are inconsequential as treatment effect-modifiers. This sparsity
structure on the set of component functions can be incorporated into representation (8):
{g∗j , β∗j , h∗k} = argmin
gj∈H(βj)j ,βj∈Θ,hk∈Hk
E
[{
Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
q∑
k=1
hk,A(Zk)
}2]
+ λ
{ p∑
j=1
‖gj‖+
q∑
k=1
‖hk‖
}
subject to E[gj,A(〈Xj , βj〉)|Xj ] = 0 ∀βj ∈ Θ (j = 1, . . . , p) and
E[hk,A(Zk)|Zk] = 0 (k = 1, . . . , q),
(9)
for some sparsity-inducing parameter λ ≥ 0. The term ∑pj=1‖gj‖+∑qk=1‖hk‖ in (9) behaves like an L1 ball
across different functional components {gj , j = 1, . . . , p; hk, k = 1, . . . , q} to encourage functional sparsity.
For example, a relatively large value of λ in (9) will result in many component functions to be exactly zero,
thereby enforcing sparsity on the set of functions {g∗j , j = 1, . . . , p; h∗k, k = 1, . . . , q}.
3 Estimation
We first consider a population characterization of the algorithm for solving (9) in Section 3.1 and then
consider a sample counterpart of the population algorithm in Section 3.2.
3.1 Population algorithm
For a set of fixed coefficient functions {βj , j = 1, . . . , p}, the minimizing component function gj ∈ H(βj)j
(and hk ∈ Hk) for each j (and each k) of the constrained objective function of (9) has a component-wise
closed-form expression.
Theorem 1. Given λ ≥ 0 and a set of fixed single-index coefficient functions {βj , j = 1, . . . , p}, the
minimizing component function gj ∈ H(βj)j of the constrained objective function of (9) satisfies:
gj,A(〈Xj , βj〉) =
[
1− λ‖fj‖
]
+
fj,A(〈Xj , βj〉) almost surely, (10)
where the function fj ∈ H(βj)j :
fj,A(〈Xj , βj〉) := E[Rj |A, 〈Xj , βj〉] − E[Rj |〈Xj , βj〉], (11)
in which
Rj = Y −
∑
j′ 6=j
gj′,A(〈Xj′ , βj′〉)−
q∑
k=1
hk,A(Zk) (12)
represents the jth (functional covariate’s) partial residual. Similarly, the minimizing component function
hk ∈ Hk of the constrained objective function of (9) satisfies:
hk,A(Zk) =
[
1− λ‖fˇk‖
]
+
fˇk,A(Zk) almost surely, (13)
where the function fˇk ∈ Hk:
fˇk,A(Zk) := E[Rˇk|A,Zk] − E[Rˇk|Zk], (14)
in which
Rˇk = Y −
p∑
j=1
gj,A(〈Xj , βj〉)−
∑
k′ 6=k
hk′,A(Zk′) (15)
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represents the kth (scalar covariate’s) partial residual. (In (10) and (13), [u]+ = max(0, u) represents the
positive part of u.)
The proof of Theorem 1 is in the Supplementary Material. Given a sparsity tuning parameter λ ≥ 0,
optimization (9) can be split into two iterative steps (Fan et al., 2014, 2015). First (Step 1 ), for a set of
fixed single-indices 〈Xj , βj〉 (j = 1, . . . , p), the component functions {gj , j = 1, . . . , p} ∪ {hk, k = 1, . . . , q}
of the model can be found by a coordinate descent procedure that fixes {gj′ ; j′ 6= j} ∪ {hk, k = 1, . . . , q}
and obtains gj by equation (10) (and that fixes {gj , j = 1, . . . , p} ∪ {hk′ ; k′ 6= k} and obtains hk by equation
(13)), and then iterates through all j and k until convergence. This step (Step 1 ) amounts to fitting a sparse
additive model (Ravikumar et al., 2009) subject to the constraint (6). Second (Step 2 ), for a set of fixed
component functions {gj , j = 1, . . . , p} ∪ {hk, k = 1, . . . , q}, the jth single-index coefficient function βj ∈ Θ
can be optimized by solving, for each j ∈ {1, . . . , p} separately:
minimize
βj∈Θ
E
[{
Rj − gj,A(〈Xj , βj〉)
}2] (j = 1, . . . , p). (16)
where the jth partial residual Rj is defined in (12). These two steps can be iterated until convergence to
obtain a population solution {g∗j , β∗j , h∗k} on the left-hand side of (9).
To obtain a sample version of the population solution, we can insert sample estimates into the population
algorithm, as in standard backfitting in estimating generalized additive models (Hastie and Tibshirani, 1999),
which we describe in the next subsection.
3.2 Sample version of the population algorithm
Only to simplify the exposition, we describe the optimization of the components gj,A(〈Xj , βj〉) (j = 1, . . . , p)
associated with the functional covariates Xj (j = 1, . . . , p), only. The regression components hk,A(Zk)
(k = 1, . . . , q) associated with the scalar covariates Zk (k = 1, . . . , q) in (9) are optimized in the same way,
except that we do not need to perform Step 2 of the alternating optimization procedure; that is, when
optimizing hk,A(Zk) (k = 1, . . . , q), we only perform Step 1.
3.2.1 Step 1
First, we consider a sample version of Step 1 of the population algorithm. Suppose we are given a set
of estimates {βˆj , j = 1, . . . , p} and the data-version of the jth partial residual Rj in (12): Rˆij = Yi −∑
j′ 6=j gˆj′,Ai(〈Xij′ , βˆj′〉)−
∑q
k=1 hˆk(Zik) (i = 1, . . . , n), where gˆj′ represents a current estimate for gj′ and
hˆk that for hk. For each j, we update the component function gj in (10) in two steps: first, estimate the
function fj in (11); second, plug the estimate of fj into
[
1− λ‖fj‖
]
+
in (10), to obtain the soft-thresholded
estimate gˆj .
Although any linear smoothers for flexible regression methods can be utilized to obtain estimators {gˆj , j =
1, . . . , p}, we shall focus on regression spline-type estimators, which are particularly simple and computationally
efficient for optimizing the proposed CFAM involving the constraint in (9). For each j, represent the function
gj ∈ H(βˆj)j on the right-hand side of (9) as:
gj,a(〈Xj , βˆj〉) = Ψj(〈Xj , βˆj〉)>θj,a (a = 1, . . . , L) (17)
for some dj-dimensional basis function Ψj(·) ∈ Rdj (e.g., B-spline basis on a set of evenly spaced knots on
a compact interval covering the observed values of 〈Xj , βˆj〉), with a set of dj-dimensional unknown basis
coefficients {θj,a}a∈{1,...,L} specific to treatment conditions A = a (a = 1, . . . , L). Given representation (17)
for the jth component function gj ∈ H(βˆj)j , the constraint E[gj,A(〈Xj , βj〉)|Xj ] = 0 in (9) on gj , for fixed
βj = βˆj , can be simplified to: E[θj,A] =
∑L
a=1 piaθj,a = 0.
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Let θj := (θ>j,1,θ>j,2, . . . ,θ>j,L)> ∈ RdjL be a vectorized version of the treatment a-specific basis coefficients
{θj,a}a∈{1,...,L}, and let us introduce the dj × djL matrix pi(j) := (pi1Idj ;pi2Idj ; . . . ;piLIdj ) in which Idj is
the dj × dj identity matrix. If we fix βj = βˆj , the constraint in (9) on the function gj can then be written in
matrix form:
pi(j)θj = 0. (18)
Given βj = βˆj , the restriction of gj ∈ H(βˆj) to the form (17) restricts also the minimizer gj in (10) to have
the form (17). In particular, the function fj in (11), if we fix βj = βˆj , is then given by:
fj,A(〈Xj , βˆj〉) = E[Rj |〈Xj , βˆj〉, A]−
L∑
a=1
piaE[Rj |〈Xj , βˆj〉, A = a]
= Ψj(〈Xj , βˆj〉)θ∗j,A −Ψj(〈Xj , βˆj〉){
L∑
a=1
piaθ
∗
j,a},
(19)
where {θ∗j,a}a∈{1,...,L} := argmin
{θj,a∈Rdj }a∈{1,...,L}
E
[{
Rj −Ψj(〈Xj , βˆj〉)>θj,A
}2]. In (19), the first term
Ψj(〈Xj , βˆj〉)θ∗j,A corresponds to the L2 projection of the jth partial residual Rj in (12) onto the class
of functions of the form (17) (without the imposition of the constraint
∑L
a=1 piaθj,a = 0), whereas the
second term −Ψj(〈Xj , βˆj〉){
∑L
a=1 piaθ
∗
j,a} simply centers the first term to satisfy the linear constraint∑L
a=1 piaθj,a = 0. Note, it can be easily shown that the function fj , as specified in the second line on the
right-hand side of (19), corresponds to the L2 projection of Rj onto the subspace of measurable functions of
the form (17) subject to the linear constraint (18).
Let the n× dj matrices Dj,a denote the evaluation matrices of the basis function Ψj(·) in (17) on 〈Xij , βˆj〉
(i = 1, . . . , n) specific to the treatment level A = a, whose ith row is the 1×dj vector Ψj(〈Xij , βˆj〉)> if Ai = a,
and a row of zeros 0> if Ai 6= a. Then the column-wise concatenation of the design matrices {Dj,a}a∈{1,...,L},
i.e., the n× djL matrix Dj = (Dj,1;Dj,2; . . . ;Dj,L), defines the model matrix associated with the vectorized
basis coefficient θj = (θ>j,1,θ>j,2, . . . ,θ>j,L)> ∈ RdjL. Then we can represent the function gj,A(〈Xj , βˆj〉) in (17),
based on the sample data, by the length-n vector:
gj = Djθj ∈ Rn (20)
subject to the linear constraint (18) on θj . (Similarly, we can represent hk,A(Zk) by a length-n vector.)
When computing the data version of the function fj in (11), which corresponds to the projection of Rj onto
the class of functions (17) subject to (18) for a given βj = βˆj , the linear constraint in (18) on θj can be
absorbed into the model matrix Dj in (20) by reparametrization, which we describe next. We can create a
djL× dj(L− 1) matrix Z(j), such that, for any arbitrary vector θ˜j ∈ Rdj(L−1) if we set θj = Z(j)θ˜j ∈ RdjL,
then the vector θj automatically satisfies the constraint (18): pi(j)θj = 0. Such a basis matrix Z(j), which
spans the null space of the linear constraint (18), can be constructed by a QR decomposition of the matrix
pi(j)>. Then representation (20) can be reparametrized, in terms of the unconstrained vector θ˜j ∈ Rdj(L−1)
by replacing Dj in (20) with the reparametrized model matrix D˜j = DjZ(j):
gj = D˜j θ˜j . (21)
Theorem 1 indicates that (for fixed βj = βˆj) the coordinate-wise minimizing function gj of the right-hand
side of (9) can be estimated based on the sample data by
gˆj =
1− λ√
1
n‖fˆj‖2

+
fˆj (22)
where fˆj = D˜j(D˜>j D˜j)−1D˜>j Rˆj , in which Rˆj = Y −
∑
j′ 6=j gˆj′ −
∑q
k=1 hˆk is the estimated jth partial
residual vector. (Similarly, we can represent the coordinate-wise minimizing function hk in (13), based on
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the observed data by a length-n vector hˆk.) Based on the sample counterpart (22) of the coordinate-wise
solution (10), if we set each βj equal to its corresponding estimate βˆj (j = 1, . . . , p), a highly efficient
(unconstrained) coordinate descent algorithm can be conducted to simultaneously optimize all component
functions {gj , j = 1, . . . , p} ∪ {hk, k = 1, . . . , q}. In (22), let sˆ(λ)j :=
[
1− λ√n/‖fˆj‖
]
+
denote the soft-
threshold shrinkage factor associated with the un-shrunk estimate fˆj . Upon convergence of the coordinate
descent, we obtain an estimate of the coefficient vector θ˜j in (21):
ˆ˜θj = sˆ(λ)j (D˜>j D˜j)−1D˜>j Rˆj (23)
which in turn implies an estimate, θˆj , of the coefficient vector θj in the original representation (20) for gj :
θˆj = (θˆ>j,1, θˆ>j,2, . . . , θˆ>j,L)> = Z(j)
ˆ˜θj
which gives an estimate of the treatment a-specific function gj,a(·) (a = 1, . . . , L):
gˆj,a(·) = Ψj(·)>θˆj,a (a = 1, . . . , L) (24)
estimated within the class of functions (17), given a tuning parameter λ ≥ 0 controlling the soft-threshold
shrinkage factor sˆ(λ)j in (23). By performing the coordinate-descent with the component-wise update rule (22),
we can obtain {gˆj , j = 1, . . . , p} ∪ {hˆk, k = 1, . . . , q}; this completes Step 1 of the alternating optimization
procedure.
Remark 1. Any scatterplot smoother can be utilized to obtain the sample counterpart (22) of the coordinate-
wise solution (10), i.e., estimation of (10) is not restricted to regression splines. To estimate the function fj
in (11), we can estimate the system of treatment a-specific functions E[Rj |〈βˆj , Xij〉, A = a] (a = 1, . . . , L)
(which corresponds to the first term on the right-hand side of (11) if we fix βj = βˆj), by performing
separate nonparametric regressions of Rˆj on regressor 〈βˆj , Xij〉 separately for each treatment condition A = a
(a = 1, . . . , L). We can also estimate the function −E[Rj |〈βj , Xij〉] (which corresponds to the second term
−E[Rj |〈βj , Xij〉] on the right-hand side of (11) if we fix βj = βˆj), by performing a nonparametric regression of
Rˆj on regressor 〈βˆj , Xij〉. Adding these two function estimates provides an estimate for fj in (11). Evaluating
this estimate of fj at the n points (〈βˆj , Xij〉, Ai) (i = 1, . . . , n) gives an estimate fˆj ∈ Rn in (22). Then we
can compute the corresponding soft-threshold estimate gˆj ∈ Rn and conduct the coordinate descent procedure
described in Algorithm 1.
3.2.2 Step 2
We now consider a sample version of Step 2 of the population algorithm that optimizes the coefficient
functions {βj , j = 1, . . . , p} on the right-hand side of (9), for a fixed set of the component function estimates
{gˆj , j = 1, . . . , p} ∪ {hˆk, k = 1, . . . , q} provided by Step 1. As an empirical approximation to (16), we consider
the optimization problem:
minimize
βj∈Θ
n∑
i=1
(
Rˆij − gˆj,Ai(〈Xij , βj〉)
)2
(j = 1, . . . , p), (25)
where Rˆij is the ith element of Rˆj ∈ Rn in (22). For each iteration, the minimization (25) can be approximately
achieved based on a first-order Taylor series approximation of the term gˆj,Ai(〈Xij , βj〉) around a current
estimate of the coefficient function, say, βˆ(c)j ∈ Θ:
n∑
i=1
(
Rˆij − gˆj,Ai(〈Xij , βj〉)
)2
≈
n∑
i=1
(
Rˆij − gˆj,Ai(〈Xij , βˆ(c)j 〉)− ˙ˆgj,Ai(〈Xij , βˆ(c)j 〉)〈Xij , βj − βˆ(c)j 〉
)2
=
n∑
i=1
(
Rˆ∗ij − 〈X∗ij , βj〉
)2
,
(26)
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where the “modified” residuals Rˆ∗ij and the “modified” regressors X∗ij are defined as:
Rˆ∗ij = Rˆij − gˆj,Ai(〈Xij , βˆ(c)j 〉) + ˙ˆgj,Ai(〈Xij , βˆ(c)j 〉)〈Xij , βˆ(c)j 〉 (i = 1, . . . , n),
X∗ij = ˙ˆgj,Ai(〈Xij , βˆ(c)j 〉)Xij (i = 1, . . . , n).
(27)
Minimization of the right-hand side of (26) over βj ∈ Θ can be performed by employing a standard
functional linear regression (e.g., Cardot et al., 2003; Marx and Eilers, 1999) with scalar response Rˆ∗ij
and (functional) regressor X∗ij . To elaborate on this briefly, we consider the P -splines functional linear
regression approach of Marx and Eilers (1999), in which the coefficient function βj in (26) is assumed to
be smooth and is represented by a prespecified (and normalized) mj-dimensional B-spline basis function
Bj(s) = (bj1(s), . . . , bjmj (s))> ∈ Rmj (s ∈ [0, 1]),
βj(s) =
mj∑
r=1
bjr(s)γjr s ∈ [0, 1]. (28)
We impose a (2nd order) difference penalty by applying the associated mj ×mj penalty matrix Sj to the
basis coefficient vector γj = (γj1, γj2, . . . , γjmj )> ∈ Rmj , to ensure appropriate smoothness. The basis Bj in
(28) uses equally-spaced knots and is rich enough to allow for the function βj in (26) to be sufficiently well
represented by the basis expansion.
SupposeXij (i = 1, . . . , n) is observed without errors and is discretized at equidistant points {sl : 0 = s1 < s2 <
. . . < srj−1 < srj = 1}. Based on an approximation of the inner product 〈Xij , βˆ(c)j 〉 ≈ ∆
∑rj
l=1Xij(sl)βˆ
(c)
j (sl),
in which ∆ denotes the distance between two neighboring discretization points and a given estimate gˆj,a(·)
in (24) available from Step 1 (and the first derivative ˙ˆgj,a(·)), we can easily approximate the quantity
˙ˆgj,Ai(〈Xij , βˆ(c)j 〉), and hence compute the “modified” residuals Rˆ∗ij and the “modified” regressors X∗ij in (27).
Let X∗j be the n× rj matrix in which the ith row corresponds to the discretized modified regressor function
X∗ij(sl) (l = 1, . . . , rj). Let Bj denote the rj × mj matrix, whose lth row (l = 1, . . . , rj) corresponds to
the B-spline basis Bj(s) ∈ Rmj , evaluated at the lth point s = sl. It follows that, based on the P -spline
representation (28) for the function βj(s) discretized at the points s = sl (l = 1, . . . , rj), we can represent the
right-hand side of (26) as:
‖R∗j −U∗j γj‖2 + ρjγ>j Sjγj (29)
where R∗j = (R∗1j , . . . , R∗nj)> ∈ Rn and U∗j = ∆X∗jBj , for some smoothing parameter ρj ≥ 0, which tunes
the P -spline penalty. We choose the tuning parameter ρj based on a generalized cross-validation (GCV)
through a grid search. For a chosen ρj , the penalized least squares minimizer γˆj of the criterion (29) is scaled
to ‖γˆj‖ = 1, so that the resulting estimate βˆj(s) =
∑mj
r=1Bjr(s)γˆjr (s ∈ [0, 1]) satisfies βˆj ∈ Θ. Minimizing
the objective (29), subject to the scale constraint ‖γj‖ = 1, over γj ∈ Rd for each j separately (j = 1, . . . , p)
gives a set of estimates {βˆj , j = 1, . . . , p}, for a given set {gˆj , j = 1, . . . , p}∪ {hˆk, k = 1, . . . , q}; this completes
Step 2 of the alternating optimization procedure.
Remark 2. If Xij is either sparsely discretized, discretized at different points across subjects or observed with
error, then an initial step for reconstructing the underlying function is required; the resulting reconstructed
function is to be treated as the original function Xij and evaluated on a dense grid of argument values {sl}.
3.2.3 Initialization and convergence criterion
At the initial iteration, we need some estimates of the single-index coefficient functions {βˆj , j = 1, . . . , p}
to initialize the single-indices {uj = 〈βˆj , Xj〉, j = 1, . . . , p}, in order to perform Step 1 (i.e., the coordinate-
descent procedure) of the estimation procedure described in Section 3.2.1. At the initial iteration, we take
βˆj(s) = 1 (s ∈ [0, 1]), i.e., we take uj =
∫ 1
0 Xj(s)ds (j = 1, . . . , p), which corresponds to the common practice
of taking a na¨ıve scalar summary of each functional covariate. The proposed algorithm that alternates
between Step 1 and Step 2 terminates when the estimates {βˆj , j = 1, . . . , p} converge. To be specific, the
algorithm terminates when maxj=1,...,p,r=1,...,mj‖(γˆjr − γˆ(c)jr )/γˆjr‖ is less than a pre-specified convergence
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tolerance. Here, γˆ(c)jr represents the current estimate of the coefficient γjr in (28) at the beginning of Step 1,
and γˆjr denotes the estimate at the end of Step 2. We summarize the computational procedure for solving
(9) in Algorithm 1.
Algorithm 1 Estimation of constrained functional additive models
1: Input: Data Xj ∈ Rn × Rrj (j = 1, . . . , p), A ∈ Rn, Y ∈ Rn, and tuning parameter λ ≥ 0
2: Output: Estimated functions {βˆj , j = 1, . . . , p} and {gˆj , j = 1, . . . , p}
3: Initialize βˆj(s) = 1 (s ∈ [0, 1]) (j = 1, . . . , p).
4: while until convergence of {βˆj , j = 1, . . . , p}, do iteratation between Step 1 and Step 2:
5: 〈Step 1〉
6: Fix {βˆj , j = 1, . . . , p}, and compute D˜j(D˜>j D˜j)−1D˜>j in (22) (j = 1, . . . , p).
7: Initialize gˆj = 0 ∈ Rn (j = 1, . . . , p).
8: while until convergence of {gˆj , j = 1, . . . , p}, do coordinate-descent iteration:
9: for j = 1, . . . , p, do
10: Update gˆj by expression (22).
11: 〈Step 2〉
12: Fix {gˆj , j = 1, . . . , p} in (24), and solve (25) based on (29); update βˆj (j = 1, . . . , p).
In Algorithm 1, if the jth soft-threshold shrinkage factor sˆ(λ)j =
[
1− λ√n/‖fˆj‖
]
+
in (22) is 0, then the
associated Xj is absent from the model. Therefore, the corresponding coefficient function βˆj will not be
updated, and this greatly reduces the computational cost when most of the shrinkage factors sˆ(λ)j are zeros.
In Algorithm 1, the smoother matrix D˜j(D˜>j D˜j)−1D˜>j in (22) (j = 1, . . . , p) needs to be computed only
once at the beginning of Step 1 given fixed {βˆj , j = 1, . . . , p}, and therefore the coordinate-descent updates
in Step 1 can be performed very efficiently (Fan et al., 2014).
The sparsity tuning parameter λ can be chosen to minimize an estimate of the expected squared error of the
estimated models over a dense grid of λ’s, estimated, for example, by a cross-validation. Alternatively, one
can utilize the network information criterion (NIC; Murata and Amari, 1994) which is a generalization of the
Akaike information criterion (AIC; Akaike, 1974) in approximating the prediction error, for the case in which
the true underlying model, i.e., the assumed model (5), is not necessarily in the class of candidate models
used to define the squared error criterion in (9).
4 Simulation study
In this section, we assess the optimal ITR estimation performance of the proposed method based on simulations.
4.1 ITR estimation performance
For the illustration in this sub-section, we generate n independent copies of p functional covariates Xi =
(Xi1(s), . . . , Xip(s)) (i = 1, . . . , n) based on Xij(sl) = Φ(sl)>x˜ij + uijl (l = 1, . . . , 50) (j = 1, . . . , p), where
each functionXij(s) is observed at 50 equally spaced points {sl}50l=1 between 0 and 1. To generate such functions
Xij(s), we use a 4-dimensional Fourier basis Φ(s) = (
√
2 sin(2pis),
√
2 cos(2pis),
√
2 sin(4pis),
√
2 cos(4pis))> ∈
R4 (s ∈ [0, 1]), along with randomly generated Fourier basis coefficients x˜ij ∈ R4 that follow N (0, I4), and
the measurement noise uijl ∈ R following N (0, 0.252), all sampled independently from each other. In addition,
we generate n independent copies of q scalar covariates Zi = (Zi1, . . . , Ziq)> ∈ Rq (i = 1, . . . , n) based on the
multivariate Gaussian distribution with each component having mean 0 and variance 1; correlations between
10
the components are given by corr(Zij , Zik) = 0.5|j−k|. We generate the responses Yi (i = 1, . . . , n) from:
Yi = δ
{ 9∑
j=2
sin(〈ηj , Xij〉) +
9∑
k=2
sin(Zik)
}
+ 2(−1)Ai
{
sin(〈β1, Xi1〉) + sin(〈β2, Xi2〉) + ξ sin(〈Xi1, Xi2〉) + Zi1/2 + sin(Zi2) + ξ sin(Zi1Zi2)
}
+ i
(30)
where we sample Ai ∈ {1, 2} with the distribution pr(Ai = 1) = pr(Ai = 2) = 0.5 independently of the
covariates (Xi,Zi) and i ∼ N (0, 0.52). In model (30), there are only four “true” treatment effect-modifiers
(Xi1, Xi2, Zi1 and Zi2) which associate the treatment variable Ai with the response Yi. The other p+ q − 4
covariates are “noise” covariates which are not useful for optimizing ITRs. In this example, we set p = q = 20,
therefore we consider a total of 40 pretreatment covariates. In model (30), we set the coefficient functions, β1
and β2, associated with the A-by-Xj (j = 1, 2) interaction effect terms to be: β1(s) = Φ(s)> (0.5, 0.5, 0.5, 0.5)
and β2(s) = Φ(s)> (0.5,−0.5, 0.5,−0.5), respectively. Further, we set the coefficient functions ηj (j = 2, . . . , 9)
associated with the Xj “main” effect terms to be: ηj(s) = Φ(s)>ηj , where, for each simulation replication,
the vector ηj ∈ R4 (j = 2, . . . , 9) is randomly generated from a multivariate Gaussian distribution and is
then rescaled to a unit L2 norm ‖ηj‖ = 1. Model (30) is indexed by a pair (δ, ξ). The parameter δ ∈ {1, 2}
controls the the contribution of the (X,Z) “main” effect term δ
{∑9
j=2 cos(〈ηj , Xij〉) +
∑9
k=2 cos(Zik)
}
to
the variance of Y , in which δ = 1 represents a relatively moderate (X,Z) main effect (contributing about the
same variance as the interaction effect does) and δ = 2 represents a relatively large (X,Z) main effect (about
4 times greater than the interaction effect) (when ξ = 0). The parameter ξ ∈ {0, 1} determines whether the
A-by-(X,Z) interaction effect component has an additive regression structure (ξ = 0) of the form (5) or
whether it deviates from an additive regression structure (ξ = 1). In the case of ξ = 0, the proposed CFAM
(5) is correctly specified, whereas, for the case of ξ = 1, it is misspecified. For each simulation replication, we
consider the following four approaches to estimating the optimal ITR Dopt.
1. The functional additive regression approach (9), estimated via Algorithm 1, with the dimension of
the B-spline basis for the functions {gj , hk} and {βj} set at dj = dk = 6 and mj = 8. The tuning
parameter λ > 0 is chosen to minimize 5-fold cross-validated prediction error of the fitted models.
2. The functional linear regression approach of Ciarleglio et al. (2018),
minimize
βj∈L2[0,1],αk∈R
E
[{
Y−
p∑
j=1
(A−1.5)〈βj , Xj〉−
q∑
k=1
(A−1.5)αkZk
}2]+λ{ p∑
j=1
(‖βj‖+ρjγ>j Sjγj)+
q∑
k=1
|αk|)
}
,
which tends to result in a sparse set {βj} ∪ {αk}, which performs estimation based on the P -
spline representation (28) for the coefficient function βj with dimension mj = 8. For each sim-
ulated dataset, the tuning parameters λ > 0 and ρ = ρj > 0 (j = 1, . . . , p) are chosen to min-
imize a 5-fold cross-validated prediction error (Ciarleglio et al., 2018), and the ITR is given by:
Dˆopt(X,Z) = arg maxa∈{1,...,L}
{∑p
j=1(a− 1.5)〈βˆj , Xj〉+ (a− 1.5)
∑q
k=1 αˆkZk
}
. Since the component
functions {gj , hk} of the regression model of Ciarleglio et al. (2018) are constrained to be linear, i.e.,
gj,a(〈βj , Xj〉) = (a− 1.5)〈βj , Xj〉 and hk,a(Zk) = (a− 1.5)αkZk, which correspond to a special case of
CFAM, we call the model of Ciarleglio et al. (2018), a constrained functional additive model with linear
component functions (CFAM-lin) for the notational simplicity.
3. The outcome weighted learning (OWL; Zhao et al., 2012) method based on a linear kernel (OWL-lin),
implemented in the R-package DTRlearn. To improve its efficiency, we employ the augmented outcome
weighted learning approach of Liu et al. (2018). The tuning parameter κ in Zhao et al. (2012) is chosen
from the grid of (0.25, 0.5, 1, 2, 4) (the default setting of DTRlearn) based on a 5-fold cross-validation.
Since there is no currently available OWL method that directly deals with functional covariates, we
simply compute a scalar summary of each functional covariate, i.e., X¯j =
∫ 1
0 Xj(s)ds ∈ R, and use X¯j
along with the other scalar covariates Zk as inputs to the augmented OWL procedure.
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4. The same approach as in 3 but based on a Gaussian radial basis function kernel (OWL-Gauss) in place
of a linear kernel. The inverse bandwidth parameter σ2n in Zhao et al. (2012) is chosen from the grid
of (0.01, 0.02, 0.04, . . . , 0.64, 1.28) and κ is chosen from the grid of (0.25, 0.5, 1, 2, 4), based on a 5-fold
cross-validation.
For each simulation run, we estimate Dopt from each of the four methods based on a training set (of size
n ∈ {250, 500}), and for evaluation of these methods, we compute the value V (Dˆopt) = E[E[Y |X,Z, A =
Dˆopt(X,Z)]] given each estimate Dˆopt, using a Monte Carlo approximation based on a random sample of size
103. Since we know the true data generating model in simulation studies, the optimal Dopt can be determined
for each simulation run. Given each estimate Dˆopt of Dopt, we report V (Dˆopt)− V (Dopt), as the performance
measure of Dˆopt. A larger value of the measure indicates better performance.
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Figure 1: Boxplots obtained from 200 Monte Carlo simulations comparing 4 approaches to estimating Dopt,
given each scenario indexed by ξ ∈ {0, 1}, δ ∈ {1, 2} and n ∈ {250, 500}. The dotted horizontal line represents
the optimal value corresponding to Dopt.
In Figure 1, we present the boxplots, obtained from 200 simulation runs, of the normalized values V (Dˆopt)
(normalized by the optimal values V (Dopt)) of the decision rules Dˆopt estimated from the four approaches, for
each combination of n ∈ {250, 500}, ξ ∈ {0, 1} (corresponding to correctly-specified or mis-specified CFAM
interaction models, respectively) and δ ∈ {1, 2} (corresponding to moderate or large main effects, respectively).
The results in Figure 1 indicate that the proposed method (CFAM) outperforms all other approaches. In
particular, if the sample size is relatively large (n = 500), for a correctly-specified CFAM (ξ = 0) interaction
underlying model, the proposed method gives a close-to-optimal performance in comparison to Dopt. With
nonlinearities present in the data model (30), CFAM-lin, which assumes a stringent linear structure on the
interaction effect term, is outperformed by CFAM that utilizes flexible component functions gj,a(·) and
hk,a(·) for the approximation of the A-by-(X,Z) interaction effects. In the absence of prior knowledge about
the interaction effects, this suggests that employing CFAM for optimizing ITRs is more suitable than the
linear interaction effect regression approach. The estimated values of the OWL methods using linear and
Gaussian kernels, respectively, are similar to each other, but both are outperformed by CFAM, even when
the true interaction effect structure deviates from CFAM (i.e., when ξ = 1), as the current OWL methods
do not directly deal with the functional covariates. If the (X,Z) “main” effect dominates the A-by-(X,Z)
interaction effect (i.e., when δ = 2), although the increased magnitude of this nuisance effect dampens the
performance of all approaches to estimating Dopt, the proposed approach outperforms all other methods. The
superior performance of CFAM is a result of its targeted estimation of the interaction effects while allowing
for an unspecified (X,Z) main effect.
4.2 Treatment effect-modifier variable selection performance
In this subsection, we will report simulation results illustrating the performance of the treatment effect-
modifier covariate selection among the covariates {Xj , j = 1, . . . , p} ∪ {Zk, k = 1, . . . , q}. The complexity of
CFAM (5) for the A-by-(X,Z) interaction effect can be summarized in terms of the size of the index set for
the component functions {gj , j = 1, . . . , p} ∪ {hk, k = 1, . . . , q} that are not identically zero, each of which
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can be either correctly or incorrectly estimated to be equal to zero. We generate 200 datasets using the
same simulation settings as in Section 4.1, i.e., using the data generating model (30) indexed by ξ ∈ {0, 1}
and δ ∈ {1, 2}, for each sample size n ∈ {100, 150, . . . , 450, 500}. As in Section 4.1, we set p = q = 20, i.e.,
we consider a total of p + q = 40 potential treatment effect-modifiers, among which there are only 4 true
treatment effect-modifiers.
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Figure 2: The proportion of the relevant covariates (i.e., the treatment effect-modifiers) correctly selected
(the “true positives”; the top gray panels), and the “noise” covariates incorrectly selected (the “false
positives”; the bottom white panels), respectively (and ±1 standard deviation), with a varying sample size
n ∈ {100, 150, . . . , 450, 500}, for each combination of ξ ∈ {0, 1} and δ ∈ {1, 2}.
Figure 2 summarizes the results of the treatment effect-modifier covariate selection performance with respect
to the true/false positive rates (the top/bottom panels, respectively), comparing the proposed CFAM approach
to the linear interaction modeling approach, CFAM-lin, of Ciarleglio et al. (2018). The results are reported
as the averages (and ±1 standard deviations) across the 200 simulated datasets, for each simulation scenario.
Figure 2 illustrates that the proportion of the correctly selecting treatment effect-modifiers out of the 4
true treatment effect-modifiers (i.e., the true positive rate; the top gray panels) of CFAM (the red solid
curves) tends to 1 as n increases from n = 100 to n = 500, while the proportion of incorrectly selecting
treatment effect-modifiers (i.e., the false positive rate; the bottom white panels) out of the 36 irrelevant
“noise” covariates tends to 0; the proportions tend to either 1 or 0 quickly for moderate main effect (δ = 1)
scenarios. Although not presented in Figure 2, when the sample size is large, for example, when n = 1000, the
false positive rate for CFAM is very close to 0 (the false positive rate = 0.04, with standard deviation 0.03)
even for a large main effect (δ = 2) and misspecified CFAM (ξ = 1) case, while the true positive rate stays
close to 1 (the true positive rate = 0.98, with standard deviation 0.08). On the other hand, the proportion
of correctly selecting treatment effect-modifiers for CFAM-lin (the blue dotted curves), even with a large n
(= 1000), tends to be only around 0.70 for all combinations of ξ and δ, due to the stringent linear regression
restriction on the A-by-(X,Z) interaction effect.
5 Application
In this section, we apply the proposed functional additive regression approach to a dataset from a study
comparing an antidepressant and placebo for treating major depressive disorder. The main objective of our
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investigation in this study was to use baseline functional covariates to guide treatment decisions when a patient
presents for treatment. The study collected baseline scalar and functional data, including electroencephalogram
(EEG) amplitude spectra curves, prior to treatment assignment. Following these baseline assessments, study
participants were randomized to either placebo (a = 1) or an antidepressant (sertraline) (a = 2). Subjects
were monitored for 8 weeks after initiation of treatment. The primary endpoint of interest was the Hamilton
Rating Scale for Depression (HRSD) score at week 8. The outcome Y was taken to be the improvement in
symptoms severity from baseline to week 8 taken as the difference: week 0 HRSD score - week 8 HRSD score,
hence a larger value of the outcome Y is considered desirable.
There were n = 179 subjects in the study. We considered p = 19 baseline functional covariates, a subset of
EEG channels from a total of 72 EEG electrodes which gives a fairly good spatial coverage of the scalp. The
locations for these 19 electrodes are indicated in Figure 3. Specifically, the functional data of interest consist
of the curves giving the current source density (CSD) amplitude spectrum values over a frequency range of 3
to 16 Hz, observed while the participants’ eyes were closed. This frequency range was scaled to [0, 1], hence
each of the functional covariates X = (X1(s), . . . , X19(s)) was defined on the interval [0, 1]. In addition, we
considered a set of 4 baseline scalar covariates, consisting of the the baseline (i.e., week 0) HRSD score (Z1),
sex (Z2) (1 for female, 0 for male), age (Z3), and the baseline HRSD-by-age interaction (Z4 = Z1 × Z3). In
this dataset, 46% of the subjects were randomized to the sertraline. The average outcomes Y for the sertraline
and placebo groups were 7.75 and 6.29, respectively. The mean age was 38.3 years, the mean baseline HSRD
score was 18.78, and 64% of the subjects were female.
The proposed CFAM estimation approach (9) selected two functional covariates: “F7” (X2) and “O2” (X12)
(the selected electrodes are indicated by the red dashed circles in Figure 3), and one scalar covariate: “baseline
HRSD” (Z1). In the left column of Figure 4, we display CSD curves corresponding to the selected functional
covariates, X2(s) and X12(s), observed from the 179 subjects. In the middle column of Figure 4, we display
the estimated single-index coefficient functions βˆj(s) (j = 2, 12) (along with the 95% confidence bands),
associated with the selected two functional covariates.
Figure 3: The locations for the 19 electrode channels (“A1” and “A2” were not used). Those marked in red
circles are the selected electrodes from the modeling method (9): “F7” and “O2”.
14
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
X2
 
Cu
rre
nt 
so
urc
e d
en
sit
y
0.0 0.2 0.4 0.6 0.8 1.0
−
1.0
−
0.5
0.0
0.5
1.0
β2
 
 
−4 −2 0 2 4 6 8 10
−
20
−
10
0
10
20
g2
<X2,β2>
Pa
rtia
l re
sid
ua
l
Sertaline group
Placebo group
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
X12
 
Cu
rre
nt 
so
urc
e d
en
sit
y
0.0 0.2 0.4 0.6 0.8 1.0
−
1.0
−
0.5
0.0
0.5
1.0
β12
 
 
−10 0 10 20
−
20
−
10
0
10
20
g12
<X12,β12>
Pa
rtia
l re
sid
ua
l
Sertaline group
Placebo group
Figure 4: Left column: observed current source density (CSD) curves from the selected channels “F7” (X2)
and “O2” (X12), for the sertraline group (red dashed curves) and for the placebo group (blue dotted curves),
over a frequency range of 3 to 16 Hz (this frequency range is scaled to [0, 1]), when the participants’ eyes
are closed. Middle column: the estimated single-index coefficient functions (β2 and β12) associated with the
selected channels X2 and X12 (and the associated 95% confidence bands). Right column: the scatter plots of
the (jth; j = 2, 12) partial residuals vs. the estimated single-indices 〈X2, β2〉 and 〈X12, β12〉. Overlaid are
the estimated treatment-specific component functions gˆj,a(·) (a = 1, 2; j = 2, 12) for the placebo group in the
dotted blue curves, and the sertraline group in the solid red curves.
The estimated single-index coefficient functions βˆj lead to data-driven scalar variables 〈βˆj , Xj〉 ∈ R. Hence,
each of the EEG amplitude spectra was reduced to an weighted average, the weights determined by the
function βˆj . These averages were selected as potential (scalar) modifiers of treatment effect, and they are
linked to differential treatment response by two corresponding nonzero component functions gˆj (j = 2, 12) in
this example. In the right column of Figure 4 (and in Figure 5), the estimated treatment a-specific component
functions gˆj,a(·) (and hˆk,a(·)) (a = 1, 2) of the selected functional (and scalar) covariates, respectively, are
displayed on the corresponding partial residual plots. These plots illustrate some nonlinear A-by-Xj (j = 2, 12)
(and A-by-Z1) interaction effects captured by the estimated component functions {gˆj , hˆk} of the model.
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Figure 5: The scatter plots of the kth partial residual vs. the kth scalar covariates Zk (k = 1): the baseline
HRSD (Z1). Overlaid are the estimated associated treatment-specific component functions h1,a(·) (a = 1, 2)
for the placebo group in the dotted blue, and the active drug group in the solid red curves.
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To evaluate the performance of ITRs (Dˆopt) estimated from the four different approaches described in
Section 4, we randomly split the data into a training set and a testing set (of size n˜) using a ratio of
5 : 1, replicated 500 times, each time estimating an ITR Dˆopt based on the training set, and its “value”
V (Dˆopt) = E[E[Y |X,Z, A = Dˆopt(X,Z)]], by an inverse probability weighted estimator (Murphy, 2005)
Vˆ (Dˆopt) = ∑n˜i=1 YiI(Ai=Dˆopt(Xi,Zi))/∑n˜i=1 I(Ai=Dˆopt(Xi,Zi)), computed based on the testing set (of size n˜).
For comparison, we also include two na¨ıve rules: treating all patients with placebo (“All PBO”) and treating
all patients with the active drug (“All DRUG”), each regardless of the individual patient’s characteristics
(X,Z). The resulting boxplots obtained from the 500 random splits are illustrated in Figure 6. A larger
value of the measure indicates better performance.
2.5
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7.5
10.0
12.5
CFAM CFAM−lin OWL−lin OWL−Gauss All PBO All DRUG
V^ (D
^
op
t )
Figure 6: Boxplots of the estimated values of the treatment rules Dˆopt estimated from 6 approaches, obtained
from 500 randomly split testing sets. Higher values are preferred.
The results in Figure 6 demonstrates that CFAM for optimizing ITRs tends to outperform other approaches
in terms of the averaged estimated values, showing some modest superiority over the na¨ıve rule of assigning
everyone to the active drug. CFAM-lin basically assigns all subjects to the active drug (see “CFAM-lin”
and “All DRUG”, which give the identical boxplots). Both the OWL-lin and OWL-Gauss approaches are
outperformed by the na¨ıve rule that assigns every subject to the active drug. Although the difference
between CFAM and the active drug (sertraline) is quite small, sertraline has been one of the most successful
antidepressant treatments available for several decades, and in comparison to the difference between the
active drug and placebo, we argue that this small difference between CFAM and the active drug still provides
a meaningful step towards “personalizing” treatment decision rules based on potentially complex patients’
pretreatment characteristics. The proposed CFAM provides a means of simultaneously identifying and
selecting treatment effect-modifiers in addition to providing a visualization for heterogeneous effects explained
by each estimated treatment effect-modifier as in Figure 5, which is an appealing feature in practice.
6 Discussion
We have developed a functional additive regression model estimation approach specifically focused on
extracting pertinent interaction effects between treatment and multiple functional/scalar covariates which is of
paramount importance in developing effective ITR’s for precision medicine. This is accomplished by imposing
an appropriate structural constraints and performing variable selection. The estimation approach utilizes
an efficient coordinate-descent algorithm for the additive component functions, coupled with a standard
functional linear regression model fitting procedure for the coefficient functions. The proposed functional
regression for ITRs extends existing (functional) linear model-based regression methods by incorporating
possibly nonlinear treatment-by-functional covariates interactions. Encouraged by our simulation results
and the application, future work will investigate the asymptotic properties of the method related to variable
selection and estimation consistency, and development of a hypothesis testing procedures for testing nonzero
interaction effects between treatment and functional covariates based on the proposed models.
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SUPPLEMENTARY MATERIAL
Supplementary Material available online includes the proof of Theorem 1.
R-package: R-package famTEMsel (Functional Additive Models for Treatment Effect-Modifier Selection)
contains R-codes to perform the methods proposed in the article, and is publicly available on GitHub
(syhyunpark/famTEMsel).
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SUPPLEMENTARY MATERIAL
Proof of Theorem 1
Proof. In order to simplify the exposition, we focus on the derivation of the minimizing component functions
gj ∈ H(βj)j (j = 1, . . . , p) associated with the functional covariates Xj (j = 1, . . . , p), only. The minimizing
component functions hk ∈ Hk (k = 1, . . . , q) associated with the scalar covariates Zk (k = 1, . . . , q) are derived
in a similar fashion. Further, for fixed βj ∈ Θ (j = 1, . . . , p), we write Xβj = 〈Xj , βj〉 ∈ R (j = 1, . . . , p), for
notational simplicity.
The squared error criterion on the right-hand side of (8) is
E
[{
Y −
p∑
j=1
gj,A(Xβj )
}2] ∝ E[Y p∑
j=1
gj,A(Xβj )−
{ p∑
j=1
gj,A(Xβj )
}2
/2
]
(with respect to {gj})
= E
[{
µ(X) +
p∑
j=1
g∗j,A(Xβ∗j )
} p∑
j=1
gj,A(Xβj )−
{ p∑
j=1
gj,A(Xβj )
}2
/2
]
= E
[
µ(X)
p∑
j=1
gj,A(Xβj )
]
+ E
[{ p∑
j=1
g∗j,A(Xβ∗j )
}{ p∑
j=1
gj,A(Xβj )
}− { p∑
j=1
gj,A(Xβj )
}2
/2
]
= E
[{ p∑
j=1
g∗j,A(Xβ∗j )
}{ p∑
j=1
gj,A(Xβj )
}− { p∑
j=1
gj,A(Xβj )
}2
/2
]
,
(31)
where the last equality follows from the constraint E[gj,A(Xβj )|Xj ] = 0 (j = 1, . . . , p) in (8)
imposed on {gj}, which implies E
[
µ(X)
∑p
j=1 gj,A
(
Xβj
)]
= E
[
E
[
µ(X)
∑p
j=1 gj,A(Xβj )|X
]]
=
E
[
µ(X)
∑p
j=1 E
[
gj,A(Xβj )|Xj
]]
= 0. From (31), for fixed {βj , j = 1, . . . , p}, we can rewrite the
squared error criterion in (8) by (omitting the components associated with the scalar covariates):
argmin
{gj∈H(βj)j }
E
[(
Y −
p∑
j=1
gj,A
(
Xβj
))2] = argmin
{gj∈H(βj)j }
E
[( p∑
j=1
g∗j,A
(
Xβ∗
j
)− p∑
j=1
gj,A
(
Xβj
))2]
. (32)
In the following, we closely follow the proof of Theorem 1 in Ravikumar et al. (2009). The Lagrangian in (9)
for fixed {βj , j = 1, . . . , p} can be rewritten as:
Q({gj};λ) := E
[( p∑
j=1
g∗j,A(Xβ∗j )−
p∑
j=1
gj,A(Xβj )
)2]+ λ p∑
j=1
‖gj‖ (33)
Fixing {βj , j = 1, . . . , p}, for each j, let us consider the minimization of (33) with respect to the component
function gj ∈ H(βj)j , holding the other component functions {gj′ , j′ 6= j} fixed. The stationary condition is
obtained by setting its Fre´chet derivative to 0. Denote by ∂jQ({gj};λ; ηj) the directional derivative with
respect to gj ∈ H(βj)j (j = 1, . . . , p) in the direction, say, ηj ∈ H(βj)j . Then, for fixed {βj , j = 1, . . . , p}, the
stationary point of the Lagrangian (33) can be formulated as:
∂jQ({gj};λ; ηj) = 2E
[
(gj − R˜j + λνj)ηj
]
= 0, (34)
where
R˜j :=
p∑
j=1
g∗j,A(Xβ∗j )−
∑
j′ 6=j
gj′,A(Xβj′ ) (35)
is the partial residual for the jth component function gj , and the function νj is an element of the subgradient
∂‖gj‖, which satisfies νj = gj/‖gj‖ if ‖gj‖ 6= 0, and νj ∈ {s ∈ H(βj)j | ‖s‖ ≤ 1}, otherwise. Applying the
iterated expectations to condition on (Xβj , A), the stationary condition (34) can be rewritten as:
2E
[(
gj − E
[
R˜j |Xβj , A
]
+ λνj
)
ηj
]
= 0. (36)
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Since the function gj − E
[
R˜j |Xβj , A
]
+ λνj ∈ H(βj)j , we can evaluate (34) (i.e., expression (36)) in the
particular direction: ηj = gj − E
[
R˜j |Xβj , A
]
+ λνj , which gives E
[(
gj − E
[
R˜j |Xβj , A
]
+ λνj
)2] = 0. This
equation implies:
gj + λνj = E
[
R˜j |Xβj , A
]
(almost surely). (37)
Let fj denote the right-hand side of (37), i.e., fj(= fj,A(Xβj )) := E
[
R˜j |Xβj , A
]
. If ‖gj‖ 6= 0, then
νj = gj/‖gj‖. Therefore, by (37), we have ‖fj‖ = ‖gj + λgj/‖gj‖‖ = ‖gj‖+ λ ≥ λ. On the other hand, if
‖gj‖ = 0, then gj = 0 (almost surely), and ‖νj‖ ≤ 1. Then, condition (37) implies that ‖fj‖ ≤ λ. This gives
us the equivalence between ‖fj‖ ≤ λ and the statement gj = 0 (almost surely). Therefore, condition (37)
leads to the following expression:
(1 + λ/‖gj‖) gj = fj (almost surely)
if ‖fj‖ > λ, and gj = 0 (almost surely), otherwise. This gives the soft thresholding update rule for gj .
Note, the underlying model (5) (if we omit the components associated with the scalar covariates) implies that∑p
j=1 g
∗
j,A(Xβ∗j ) = E[Y |X, A]− µ(X). Thus, (35) can be equivalently written as: R˜j = E[Y |X, A]− µ(X)−∑
j′ 6=j gj′,A(Xβj′ ). Therefore, the function fj,A(Xβj ) = E
[
R˜j |Xβj , A
]
can be written by:
fj,A(Xβj ) = E
[
E[Y |X, A]− µ(X)−
∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj , A
]
= E
[
E[Y |X, A]−
∑
j′ 6=j
gj′,A(Xj′) | Xβj , A
]− E[µ(X) | Xβj , A]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj , A
]− E[µ(X) | Xβj ]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj , A
]− E[µ(X) + p∑
j=1
g∗j,A
(
Xβ∗
j
) | Xβj ]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj , A
]− E[Y | Xβj ]
= E
[
Y −
∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj , A
]− E[Y −∑
j′ 6=j
gj′,A(Xβj′ ) | Xβj
]
= E
[
Rj | Xβj , A
]− E[Rj | Xβj ],
where the fourth equality follows from the identifiability constraint (6) of the underlying model (5), and the
sixth equality follows from the optimization constraint E[gj′,A(Xβj′ )|Xj ] = 0 (j′ 6= j) implied by (8) imposed
on {gj′ , j′ 6= j}. This gives the desired expression (11).
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